SURAKSHA DIAGNOSTIC LIMITED

BSE: SURAKSHA544293ISIN INE877V01027

Healthcare
Healthcare Service Provider
BSE Healthcare

Share price

₹333.10+6.05 (+1.85%)

as of 4 Nov 2026

Prices adjusted for splits and bonuses; cash dividends excluded. Volume shows actual shares traded.

52W high: ₹359.00
52W low: ₹224.10
Off 52W high: -7.21%
1M return: +0.62%
3M return: +32.58%
6M return: +18.65%
1Y return: +2.54%
20D avg volume: 3,186
50 DMA: ₹327.67
200 DMA: ₹286.83

Key ratios Consolidated

Market cap: ₹1,735 Cr
Current price: ₹333.10
52W high / low: ₹359.00 / ₹224.10
Face value: ₹2.00
P/E: 49.46
P/B: 7.09
EPS (TTM): ₹6.73
Book value / share: ₹47.01
ROE: —
ROCE: 14.70%
Operating margin: —
Net margin: —
Debt / equity: 0.01
Net debt: ₹-1.47 Cr
Interest cover: 4.55
Dividend yield: 0.15%
Dividend / share (TTM): ₹0.50
Payout: 7.43%
Cash conversion cycle: 11.9 days

Financials

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q4 FY24
Income statement
	87.65	81.41	77.69	78.73	72.59	65.09	59.51	66.75	—
	1.09	0.79	0.62	0.85	0.91	0.82	0.60	1.31	—
	88.73	82.20	78.31	79.58	73.49	65.91	60.11	68.07	—
	72.21	72.22	68.25	67.53	61.02	56.70	52.06	54.43	—
	9.99	10.16	8.67	8.90	8.75	8.85	6.10	7.93	—
	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—
	14.41	13.67	13.42	13.39	12.78	10.20	11.29	11.02	—
	3.72	3.92	3.16	2.78	2.71	2.06	1.98	2.12	—
	11.28	11.26	10.56	10.14	9.48	8.73	8.83	8.75	—
	32.80	33.21	32.44	32.32	27.31	26.86	3.41	3.10	—
	16.53	9.98	10.06	12.05	12.47	9.21	8.05	13.63	—
	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—
	16.53	9.98	10.06	12.05	12.47	9.21	8.05	13.63	—
	3.68	3.82	2.82	3.22	3.29	2.04	2.06	3.48	—
	12.85	6.16	7.24	8.83	9.18	7.17	5.99	10.16	—
	2.50	1.21	1.44	1.73	1.80	1.42	1.18	1.94	—
Key metrics
	31.53	25.16	23.78	24.97	24.66	20.00	18.86	24.50	—
	36.00%	30.90%	30.60%	31.70%	34.00%	30.70%	31.70%	36.70%	—
	14.70%	7.60%	9.30%	11.20%	12.60%	11.00%	10.10%	15.20%	—
	—	3.60%	—	4.40%	—	3.90%	—	—	—
	20.70%	25.10%	30.50%	17.90%	—	—	—	—	—
	40.00%	-14.10%	20.90%	-13.10%	—	—	—	—	—

Metric	TTM	FY26	FY25	FY24
Income statement
	325.48	310.41	252.09	—
	3.35	3.16	3.85	—
	328.82	313.58	255.94	—
	280.21	269.02	214.53	—
	37.72	36.48	29.52	—
	0.00	0.00	0.00	—
	54.89	53.26	42.89	—
	13.58	12.55	8.39	—
	43.24	41.45	35.30	—
	130.77	125.29	98.44	—
	48.62	44.56	41.41	—
	0.00	0.00	0.00	—
	48.62	44.56	41.41	—
	13.54	13.15	10.43	—
	35.08	31.40	30.98	—
	6.88	6.18	5.97	—
Key metrics
	105.44	98.56	85.10	—
	32.40%	31.80%	33.80%	—
	10.78%	10.10%	12.30%	—
	—	14.70%	17.10%	—
	23.32%	23.10%	—	—
	7.94%	1.40%	—	—
	—	14.49	21.34	—
	—	2.61	2.05	—
	—	0.01	0.03	—
	—	-1.47	3.58	—
	—	11.9	12.0	—
Balance sheet
	—	448.12	333.52	—
	—	62.58	47.15	—
	—	3.21	2.25	—
	—	22.76	13.81	—
	—	8.14	8.05	—
	—	4.64	2.66	—
	—	193.58	147.14	—
	—	20.86	13.64	—
	—	59.65	42.72	—
	—	1.74	5.83	—
	—	1.56	2.95	—
	—	0.18	2.88	—
	—	243.48	210.23	—
Cash flow
	—	81.83	63.36	—
	—	-52.17	-39.58	—
	—	-28.69	-24.05	—
	—	67.34	42.02	—

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q4 FY24
Income statement
	84.09	78.56	75.58	76.26	70.28	64.15	58.57	65.95	—
	1.56	1.30	0.99	0.97	1.10	0.94	0.97	1.26	—
	85.65	79.86	76.57	77.23	71.38	65.09	59.55	67.20	—
	69.44	69.30	65.60	64.66	58.25	55.05	51.13	53.02	—
	9.71	10.03	8.58	8.80	8.69	8.59	5.99	7.83	—
	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—
	13.85	13.23	13.03	12.99	12.41	10.00	11.01	10.71	—
	3.67	3.87	3.10	2.72	2.66	2.06	2.03	2.07	—
	10.60	10.69	10.11	9.65	9.15	8.66	8.62	8.58	—
	31.60	31.49	30.78	30.50	25.34	25.74	3.27	2.86	—
	16.21	10.56	10.97	12.57	13.12	10.04	8.42	14.18	—
	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—
	16.21	10.56	10.97	12.57	13.12	10.04	8.42	14.18	—
	3.63	3.85	2.83	3.21	3.27	2.03	2.06	3.43	—
	12.58	6.71	8.14	9.36	9.85	8.01	6.36	10.75	—
	2.42	1.29	1.56	1.80	1.89	1.54	1.22	2.02	—
Key metrics
	30.48	25.12	24.18	24.94	24.93	20.76	19.07	24.83	—
	36.20%	32.00%	32.00%	32.70%	35.50%	32.40%	32.60%	37.60%	—
	15.00%	8.50%	10.80%	12.30%	14.00%	12.50%	10.90%	16.30%	—
	—	3.70%	—	4.50%	—	4.10%	—	—	—
	19.60%	22.50%	29.00%	15.60%	—	—	—	—	—
	27.70%	-16.20%	28.00%	-12.90%	—	—	—	—	—

Metric	TTM	FY26	FY25	FY24
Income statement
	314.49	300.68	249.10	—
	4.82	4.35	4.38	—
	319.31	305.03	253.48	—
	269.00	257.82	209.62	—
	37.12	36.10	28.95	—
	0.00	0.00	0.00	—
	53.10	51.67	41.91	—
	13.36	12.34	8.39	—
	41.05	39.60	34.73	—
	124.37	118.10	95.65	—
	50.31	47.22	43.86	—
	0.00	0.00	0.00	—
	50.31	47.22	43.86	—
	13.52	13.15	10.42	—
	36.79	34.06	33.44	—
	7.07	6.54	6.42	—
Key metrics
	104.72	99.16	86.98	—
	33.30%	33.00%	34.90%	—
	11.70%	11.30%	13.40%	—
	—	15.20%	17.70%	—
	21.45%	20.70%	—	—
	5.20%	1.90%	—	—
	—	30.11	27.41	—
	—	2.36	1.88	—
	—	0.01	0.03	—
	—	-0.64	4.35	—
	—	16.5	13.4	—
Balance sheet
	—	450.14	333.10	—
	—	63.47	44.27	—
	—	2.30	1.48	—
	—	24.86	15.06	—
	—	8.12	8.02	—
	—	4.56	3.15	—
	—	168.53	139.38	—
	—	19.42	13.99	—
	—	57.36	38.21	—
	—	1.66	5.83	—
	—	1.53	2.95	—
	—	0.13	2.88	—
	—	249.80	214.31	—
Cash flow
	—	80.23	62.80	—
	—	-51.25	-39.28	—
	—	-28.15	24.15	—
	—	50.12	35.39	—

Compounded growth

Standalone

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Sales YoY (TTM): +21.45%
Profit YoY (TTM): +5.20%

Consolidated

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Sales YoY (TTM): +23.32%
Profit YoY (TTM): +7.94%

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Sep 2026

Promoter holding: 49.10%

Quarter	September 2026	June 2026
Promoter %	49.10%	49.10%

Holder	Type	Holding	Previous	Change
RITU MITTAL	Promoter	15.93%	15.93%	0.00%
ORBIMED ASIA II MAURITIUS LIMITED	Public	12.88%	12.88%	0.00%
SATISH KUMAR VERMA	Promoter	10.84%	10.84%	0.00%
SARLA KEJRIWAL	Promoter Group	9.23%	9.23%	0.00%
NIPPON LIFE INDIA TRUSTEE LTD-A/C NIPPON INDIA PHA	Public	7.48%	7.48%	0.00%
KOTAK SMALL CAP FUND	Public	6.99%	6.51%	+0.48%
SOMNATH CHATTERJEE	Promoter	5.10%	5.10%	0.00%
Tinni Investments Limited	Promoter Group	4.62%	4.62%	0.00%
ADITYA BIRLA SUN LIFE TRUSTEE PRIVATE LIMITED A/C	Public	3.79%	3.79%	0.00%
Dneema Overseas Private Limited	Promoter Group	3.21%	3.21%	0.00%
BANDHAN BALANCED ADVANTAGE FUND	Public	1.09%	1.32%	-0.23%
Aparajita Chatterjee	Promoter Group	0.10%	0.10%	0.00%
Bipul Mittal	Promoter Group	0.04%	0.04%	0.00%
Bipul Mittal HUF	Promoter Group	0.03%	0.03%	0.00%
Rama Special Steel Private Limited	Promoter Group	0.00%	0.00%	0.00%

Public shareholders are disclosed individually only above 1%.

Peer comparison

Company	Mkt cap (₹ Cr)	Price (₹)	P/E	ROCE	Sales YoY	Profit YoY	1Y return
Dr. Lal Pathlabs Limited	34,056	2,028.95	57.92	25.70%	+16.71% TTM	+8.93% TTM	+28.73%
Vijaya Diagnostic Centre Limited	14,676	1,424.85	72.05	19.20%	+24.48% TTM	+33.96% TTM	+39.02%
Metropolis Healthcare Limited	12,075	582.05	53.57	15.70%	+19.84% TTM	+41.90% TTM	+14.58%
Thyrocare Technologies Limited	7,883	495.25	55.01	33.60%	+21.99% TTM	+13.16% TTM	+9.41%
Nephrocare Health Services Limited	6,242	620.75	48.72	13.70%	—	—	—
SURAKSHA DIAGNOSTIC LIMITED	1,735	333.10	49.46	14.70%	+23.32% TTM	+7.94% TTM	+2.54%
Krsnaa Diagnostics Limited	1,566	482.90	15.97	10.60%	+15.90% TTM	+16.02% TTM	-37.25%
3B BlackBio Dx Limited	1,142	1,330.25	20.29	22.60%	+54.30% TTM	+14.75% TTM	-1.52%
HEALTH X PLATFORM LIMITED	863	271.20	-33.11	—	+28.85% TTM	+82.45% TTM	-8.73%
ONE GLOBAL SERVICE PROVIDER LIMITED S	861	440.70	11.65	65.70%	+161.55% TTM	+178.28% TTM	+21.17%
Gaudium IVF and Women Health Limited	779	107.05	—	23.10%	—	—	—
Aspira Pathlab & Diagnostics Limited S	144	140.35	-318.98	2.90%	+14.50% TTM	-117.58% TTM	+132.68%
Choksi Laboratories Ltd. S	142	203.90	65.77	12.30%	+10.74% TTM	+44.00% TTM	+38.05%
STAR IMAGING AND PATH LAB LIMITED	120	68.90	—	22.60%	—	—	-51.78%
MODERN DIAGNOSTIC & RESEARCH CENTRE LIMITED S	86	57.00	—	11.20%	—	—	—
Sharma East India Hospitals And Res S	34	87.05	24.11	14.20%	+14.13% TTM	-9.85% TTM	-38.28%
BANDARAM PHARMA PACKTECH LIMITED	34	19.03	25.81	4.70%	+114.59% TTM	+454.17% TTM	-22.14%
N.G.Industries Ltd. S	34	100.00	17.39	6.30%	+2.18% TTM	-74.06% TTM	-23.28%
Deccan Health Care Limited	29	12.00	11.40	3.20%	-0.37% TTM	+145.63% TTM	-29.41%
Chennai Meenakshi Multispeciality Hospital Ltd. S	27	36.78	-32.26	-2.80%	+0.08% TTM	+6.59% TTM	-29.27%
SAMSRITA LABS LIMITED	27	11.93	-3.33	-73.40%	—	—	-43.35%
Tejnaksh Healthcare Limited	26	12.83	21.19	5.90%	-12.97% TTM	-33.15% TTM	-27.02%
Transgene Biotek Ltd.	17	2.57	-12.11	-0.50%	-14.81% TTM	-23.85% TTM	-28.21%
Dolphin Medical Services Ltd. S	11	7.11	59.25	0.60%	-1.25% TTM	+700.00% TTM	+246.83%
Looks Health Services Limited S	11	10.08	504.00	0.20%	-41.89% TTM	-57.14% TTM	+101.20%

Filings & corporate actions

Recent announcements

Intimation regarding change in the Corporate Office of Registrar to an issue and Share Transfer Agent(RTA) of the Company with effect from 01 December, 20263 Nov 2026 · Company Update / General
The Board was aprised that the Company had received a notice dated 31-08-2026 from NSE, intimating that Company of non-Compliance with Regulation 31 of SEBI(LODR) Regulation 2015. The same ....14 Oct 2026 · Company Update / General
Appointment of Ms. Shreya Arora as Company Secretary & Compliance Officer of the Company14 Oct 2026 · Company Update / Change in Management
Certificate under Regulation 74(5) of SEBI (Depositaries and Participants) Regulations, 2018 for the quarter ended 30 September, 2026.5 Oct 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Pursuant to provision of SEBI (Prohibition of Insider Trading) Regulation, 2015 as amended from time to time, we wish to inform you that in terms of the Company''s Code of Conduct for regulation, ....28 Sep 2026 · Insider Trading / SAST / Closure of Trading Window
Voting Results & Scrutinizer''s Report for the 21st Annual General Meeting (AGM) of the Company held on 22nd September, 202624 Sep 2026 · AGM/EGM / AGM
Revised Proceedings of the 21st Annual General Meeting (AGM) of the Company23 Sep 2026 · AGM/EGM / AGM
Proceedings of the 21st Annual General Meeting of the Company held on 22nd September, 2026.22 Sep 2026 · AGM/EGM / AGM
Please find enclosed the Newspaper Advertisement published on Monday, 31st August, 2026 with respect to the "Notice of 21st Annual General Meeting and e-voting information."31 Aug 2026 · Company Update / Newspaper Publication
Please find enclosed the letter sent to those shareholders whose e-mail address are not registered, providing the web link of the Company''s website from where Annual Report for the Financial ....27 Aug 2026 · Company Update / General
Please find enclosed the Notice of 21st Annual General Meeting of the Company scheduled to be held on 22nd September, 202627 Aug 2026 · AGM/EGM / AGM
Please find enclosed the Annual Report of the Company for the financial year 2025-26, including Notice dated 12th August, 2026 convening the 21st Annual General Meeting (AGM) of the Company ....27 Aug 2026 · Others / Reg. 34 (1) Annual Report
Newspaper Publication for Notice of the 21st Annual General Meeting(AGM) of the Company25 Aug 2026 · Company Update / Newspaper Publication
Newspaper Publication for Notice of the 21st Annual General Meeting (AGM) of the Company25 Aug 2026 · Company Update / Newspaper Publication
The text Transcript of Earning call held on 13 August 2026 at 11:30 a.m. (IST)with respect to the unaudited (Standalone & Consolidated) Financial Results of the Company for the quarter ....17 Aug 2026 · Company Update / Earnings Call Transcript
Intimation of outcome of audio recording of analyst/Institutional Investor/Organizations meet-"Earning Call" which was held today i.e. 13 August 202613 Aug 2026 · Company Update / Analyst / Investor Meet
Intimation of outcome of audio recording of Analyst/Institutional Investor/ Organizations meet-"Earning call" held today i.e. 13 Auust 202613 Aug 2026 · Company Update / Analyst / Investor Meet
Newspaper Publication of unaudited ( Standalone & Consolidated) Financial Results of the Company for the quarter ended 30 June 2026.13 Aug 2026 · Company Update / Newspaper Publication
Investor Presentation for quarter 1 ended 30 June 202612 Aug 2026 · Company Update / Investor Presentation
Press release in respect of unaudited ( Standalone and Consolidated) Financial Results for the quarter ended 30 June 202612 Aug 2026 · Company Update / Press Release / Media Release
Revised Record date if 15 September 2026 has been fixed12 Aug 2026 · Corp. Action / Record Date
Appointment of Chief Financial Officer of Mr. Dinesh Gupta12 Aug 2026 · Company Update / Change in Management
Approved unaudited financial results ( Standalone and Consolidated) of the company for quarter ended 30 June 202612 Aug 2026 · Result / Financial Results
Outcome of Board meeting held today, i.e 12 August 202612 Aug 2026 · Board Meeting / Outcome of Board Meeting
We wish to inform that the 21st Annual General Meeting of the Company which was scheduled to be held on Wednesday, 02 September 2026, stands postponed to a future date due to certain unavoidable ....10 Aug 2026 · AGM/EGM / AGM
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that there will be a Conference Call viz. ''Earnings Call'' ....7 Aug 2026 · Company Update / Analyst / Investor Meet
Suraksha Diagnostic Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve Intimation of Board Meeting ....4 Aug 2026 · Board Meeting / Board Meeting
Certificate under Regulation 74(5) of SEBI (Depositaries and Participants) Regulations, 2018 for the quarter ended 30 June, 2026.8 Jul 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Pursuant to provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015 as amended from time to time, we wish to inform you that in terms of the Company''s Code of Conduct for ....15 Jun 2026 · Insider Trading / SAST / Closure of Trading Window
Resignation of Ms. Mamta Jain, Company Secretary & Compliance Officer and Key Managerial Personnel (KMP) of the Company.9 Jun 2026 · Company Update / Resignation of Company Secretary / Compliance Officer
Transcript of the Earning Call held on Friday, 22 May 2026 with respect to the Audited (Standalone and Consolidated) Financial results of the Company for the quarter and year ended March 31, 2026.27 May 2026 · Company Update / Earnings Call Transcript
Submission of Annual Secretarial Complinace Report pursuant to regulations 24A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the financial year ended 31 March, 2026.22 May 2026 · Company Update / Reg.24(A)-Annual Secretarial Compliance
Intimation of audio recording of Analysts/Institutional Investors/Organisations meet-''Earnings Call''22 May 2026 · Company Update / Analyst / Investor Meet
Newspaper publication of audited (standalone and consolidated) financial results of Company for quarter and financial year ended 31 March 2026.22 May 2026 · Company Update / Newspaper Publication
Press release in respect of audited (standalone and consolidated) financial results for the quarter and financial year ended 31 March 202621 May 2026 · Company Update / Press Release / Media Release
Investor Presentation for Q4 & FY 2025-2621 May 2026 · Company Update / Investor Presentation
Re-appointment of M/s S Chhaparia & Associates as Cost Auditor for financial year ended 31 March 2026.21 May 2026 · Company Update / Change in Management
Appointment of M/s Suresh Surana & Associates LLP as Internal Auditor of the Company for FY 2026-27.21 May 2026 · Company Update / Change in Management
Recommended dividend of ? 0.50 (Fifty Paise) per Equity Share of face value of ? 2/- each for FY 2025-2621 May 2026 · Corp. Action / Dividend
Results-Financial results for quarter and financial year ended 31 March 202621 May 2026 · Result / Financial Results

Corporate actions

Purpose	Ex date	Record date	Payment date
Final Dividend - Rs. - 0.5000	15 Sep 2026	15 Sep 2026	—